0
CLINICAL NOTES   |    
CLINICAL EVALUATION OF A NEW PHENOTHIAZINE TRANQUILIZER, FLUPHENAZINE (PROLIXIN)
IRVING J. TAYLOR
Am J Psychiatry 1959;116:457-458.
View Author and Article Information

Taylor Manor Hospital, Ellicott City, Md.

text A A A
PDF of the full text article.
Abstract

Of the patients treated with fluphenazine, 141 of the 166 who were evaluated (85%) improved, 23 responded poorly, and 24 were for appropriate reasons not evaluated. The average dose was 5 mg. on admission, 5 mg. the next morning and 2.5 mg. thereafter as a single morning dose. Extrapyramidal effects were seen in patients receiving higher doses (5 to 10 mg. daily) but these were controllable by reducing the dosage.Fluphenazine is an effective tranquilizer and is the most potent of the phenothiazines previously employed here, being about 25 times as potent as chlorpromazine. The rapid and sustained action of the drug and its administration as a single daily dose are distinctly advantageous.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition > Chapter 26.  >
What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 51.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 42.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 42.  >
Topic Collections
Psychiatric News
PubMed Articles
Causes of rhabdomyolysis.
Mayo Clinic proceedings. Mayo Clinic 1995 Dec